NEW YORK (GenomeWeb News) — Qiagen said today that it will market and distribute Biomatrica’s room temperature DNA-storage technology.
Under the agreement, Qiagen will pay Biomatrica an up-front fee, followed by development milestone payments, commission, and royalties.
Biomatrica’s sample-storage system uses its SampleMatrix technology, which forms a protective seal around biomolecules. The samples are accessed through rehydration, the company said.
Biomatrica also offers sample-management software that can be used in low- and high-throughput research, and with biobanks.
Qiagen said the SampleMatrix technology is “highly synergistic” with its own sample-prep technology and is usable with its PCR-based genotyping and molecular testing products, and for comparative genomic studies.
The company said it expects to expand the exclusive agreement in the future to include Biomatrica’s technology to stabilize, ship, and store DNA molecules in blood and buccal-swab samples.
Financial details of the agreement were not released.